Dr. Plas received his PhD from Washington University studying lymphocyte antigen receptor signal transduction with Dr. Matthew L. Thomas. He studied tumor cell metabolism in apoptosis control with Dr. Craig Thompson at the University of Chicago and the University of Pennsylvania. He has led a research laboratory at the University of Cincinnati since 2004, focusing on counteracting PTEN deficiency in cancer through the targeting of signaling and metabolic pathways.